Aortic stiffness, inflammation, denutrition and type 2 diabetes in the elderly

Diabetes and Metabolism

Volumn 38, Issue 1, 2012, Pages 68-75

  Blacher, J ^a   Protogerou, A D ^a   Henry, O ^a   Czernichow, S ^a   Iaria, P ^a   Zhang, Y ^a   Agnoletti, D ^a   Safar, M E ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Arterial stiffness; Cardiovascular risk factor; Denutrition; Elderly; Inflammation; Mortality; Pulse wave velocity; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; OROSOMUCOID; PREALBUMIN; SERUM ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PROTEIN BLOOD LEVEL; PULSE WAVE; SEDIMENTATION RATE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MALNUTRITION; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; PULSATILE FLOW; QUESTIONNAIRES; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84856732043     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.07.006     Document Type: Article

References (41)

1. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146.
2. Staessen J.A., Fagard R., Thijs L., Celis H., Birkenhager W.H., Bulpitt C.J., et al. Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly. Arch Intern Med 1998, 158:1681-1691.
3. Gueyffier F., Bulpitt C., Boissel J.P., Schron E., Ekbom T., Fagard R., et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999, 353:793-796.
4. Satish S., Zhang D.D., Goodwin J.S. Clinical significance of falling blood pressure among older adults. J Clin Epidemiol 2001, 54:961-967.
5. Protogerou A.D., Safar M.E., Iaria P., Safar H., Le Dudal K., Filipovsky J., et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 2007, 50:172-180.
6. Iso H., Jacobs D.R., Wentworth D., Neaton J.D., Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989, 320:904-910.
7. Casiglia E., Mazza A., Tikhonoff V., Scarpa R., Schiavon L., Pessina A.C. Total cholesterol and mortality in the elderly. J Intern Med 2003, 254:353-362.
8. Schatz I.J., Masaki K., Yano K., Chen R., Rodriguez B.L., Curb J.D. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001, 358:351-355.
9. Tikhonoff V., Casiglia E., Mazza A., Scarpa R., Thijs L., Pessina A.C., et al. Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 2005, 53:2159-2164.
10. Volpato S., Leveille S.G., Corti M.C., Harris T.B., Guralnik J.M. The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 2001, 49:1142-1147.
11. Weverling-Rijnsburger A.W., Jonkers I.J., van Exel E., Gussekloo J., Westendorp R.G. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003, 163:1549-1554.
12. Mazzali G., Di Francesco V., Zoico E., Fantin F., Zamboni G., Benati C., et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. Am J Clin Nutr 2006, 84:1193-1199.
13. Volpato S., Palmieri E., Fellin R., Zuliani G. Acute phase markers are associated with reduced plasma lipid levels in a population of hospitalized elderly patients. Gerontology 2000, 46:22-27.
14. Kalmijn S., Curb J.D., Rodriguez B.L., Yano K., Abbott R.D. The association of body weight and anthropometry with mortality in elderly men: the Honolulu Heart Program. Int J Obes 1999, 23:395-402.
15. Stevens J., Cai J., Pamuk E.R., Williamson D.F., Thun M.J., Wood J.L. The effect of age on the association between body mass index and mortality. N Engl J Med 1998, 338:1-7.
16. Pyorala M., Miettinen H., Laakso M., Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998, 98:398-404.
17. Reaven G.M. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
18. Vischer U., Safar M.E., Safar H., Iaria P., Le Dudal K., Henry O., et al. Metabolic and hemodynamic determinants of mortality in a frail geriatric population: is there a "reverse metabolic syndrome" ?. Diabetes Metab 2009, 35:108-114.
19. Chumlea W.C., Guo S.S., Wholihan K., Cockram D., Kuczmarski R.J., Johnson C.L. Stature prediction equations for elderly non-Hispanic white, non-Hispanic black, and Mexican-American persons developed from NHANES III data. J Am Diet Assoc 1998, 98:137-142.
20. Asmar R., Benetos A., Topouchian J., Laurent P., Pannier B., Brisac A.M., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995, 26:485-490.
21. Nichols W.W., O'Rourke M McDonald's blood flow in arteries: theoretical experimental and clinical principles 2006, E. Arnold, London/Sydney/Auckland, [p. 49-94: p. 193-233, p. 339-402, p. 435-502]. 4th ed.
22. Meaume S., Benetos A., Henry O.F., Rudnichi A., Safar M.E. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001, 21:2046-2050.
23. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. Management of arterial hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
24. O'Brien E., Mee F., Atkins N., O'Malley K. Short report: accuracy of the Dinamap portable monitor, model 8100 determined by the British Hypertension Society protocol. J Hypertens 1993, 11:761-763.
25. Messerli F.H., Ventura H.O., Amodeo C. Osler's maneuver pseudohypertension. N Engl J Med 1985, 312:1348-1351.
26. Safar M.E. Epidemiological findings imply that goals for drug treatment of hypertension need to be revised. Circulation 2001, 103:1188-1190.
27. Guerin A.P., Blacher J., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001, 103:987-992.
28. Bigaard J., Frederiksen K., Tjonneland A., Thomsen B.L., Overvad K., Heitmann B.L., et al. Body fat and fat-free mass and all-cause mortality. Obesity Res 2004, 12:1042-1049.
29. Janssen I., Katzmarzyk P.T., Ross R. Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 2005, 53:2112-2118.
30. Jee S.H., Sull J.W., Park J., Lee S.Y., Ohrr H., Guallar E., et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006, 355:779-787.
31. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007, 128:83-91.
32. Henry O.F., Blacher J., Verdavaine J., Duviquet M., Safar M. Alpha-1 glycoprotein acid is a strong independent predictor of in-hospital death in the oldest old. Age Ageing 2003, 32:37-42.
33. Raynaud-Simon A., Lafont S., Berr C., Dartigues J.F., Le Bouc Y. Orosomucoid: a mortality risk factor in elderly people living in the community?. Clin Nutr 2002, 21:45-50.
34. Christiansen M.S., Hommel E., Magid E., Feldt-Rasmussen B. Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with type II diabetes. Diabetologia 2002, 45:115-120.
35. Engstrom G., Stavenow L., Hedblad B., Lind P., Eriksson K.F., Janzon L., et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 2003, 52:442-447.
36. Duncan B.B., Schmidt M.I., Pankow J.S., Ballantyne C.M., Couper D., Vigo A., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003, 52:1799-1805.
37. Langer R.D., Ganiats T.G., Barret-Connor F. Factors associated with paradoxical survival at higher blood pressures in the very old. Am J Epidemiol 1991, 134:29-38.
38. Verhave J.C., Fesler P., du Cailar G., Ribstein J., Safar M.E., Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 2005, 45:586-591.
39. Mitchell G.F. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol 2008, 105:1652-1660.
40. Kullo I.J., Seward J.B., Bailey K.R., Bielak L.F., Grossardt B.R., Sheedy PF, et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005, 18:1123-1129.
41. Mahmud A., Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005, 46:1118-1122.